FOG-001 in Locally Advanced or Metastatic Solid Tumors
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Benjamin Oshrine
Parabilis Medicines, Inc.
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Integrated Clinical Oncology Network (icon)
South Brisbane, Queensland, Australia
Recruiting - Peter Maccallum Cancer Centre
Melbourne, Victoria, Australia
Recruiting
- Mayo Clinic
Phoenix, Arizona, United States
Recruiting - Honor Health
Scottsdale, Arizona, United States
Recruiting - Arizona Cancer Center at University of Arizona
Tucson, Arizona, United States
Recruiting - University of California, Los Angeles (ucla)
Los Angeles, California, United States
Recruiting - Stanford Cancer Institute, Stanford University
Palo Alto, California, United States
Recruiting - University of California San Francisco, Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
Recruiting - Sarcoma Oncology Center
Santa Monica, California, United States
Recruiting - University of Colorado
Aurora, Colorado, United States
Recruiting - Yale University School of Medicine
New Haven, Connecticut, United States
Recruiting - Johns Hopkins University, Sibley Memorial Hospital
Washington D.C., District of Columbia, United States
Recruiting - Mayo Clinic
Jacksonville, Florida, United States
Recruiting - Florida Cancer Specialists
Lake Mary, Florida, United States
Terminated - Johns Hopkins University, the Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, United States
Recruiting - Dana Farber Cancer Institute
Boston, Massachusetts, United States
Recruiting - Massachusetts General Hospital
Boston, Massachusetts, United States
Recruiting - M Health Fairview University of Minnesota Medical Center
Minneapolis, Minnesota, United States
Recruiting - Mayo Clinic
Rochester, Minnesota, United States
Recruiting - Washington University School of Medicine
St Louis, Missouri, United States
Recruiting - Memorial Sloan Kettering Cancer Center
New York, New York, United States
Recruiting - Duke University
Durham, North Carolina, United States
Recruiting - Cleveland Clinic
Cleveland, Ohio, United States
Recruiting - University Hospitals Cleveland Medical Center, Seidman Cancer Center
Cleveland, Ohio, United States
Recruiting - Oregon Health and Science University
Portland, Oregon, United States
Recruiting - University of Pennsylvania, Perelman School of Medicine
Philadelphia, Pennsylvania, United States
Recruiting - University of Pittsburgh Medical Center, Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
Recruiting - Sarah Cannon Research Institute
Nashville, Tennessee, United States
Recruiting - Vanderbilt Ingram Cancer Center
Nashville, Tennessee, United States
Recruiting - the University of Texas Md Anderson Cancer Center
Houston, Texas, United States
Recruiting - South Texas Accelerated Research Therapeutics, Llc
San Antonio, Texas, United States
Recruiting - University of Virginia
Charlottesville, Virginia, United States
Recruiting - University of Wisconsin, Carbone Cancer Center
Madison, Wisconsin, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 May 2023
- Primary completion
- 1 Apr 2027
- Completion
- 31 Aug 2027
- Last update posted
- 17 Aug 2026
- Registered enrollment
- 619
- Registry id
- NCT05919264
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.